EBS - Emergent BioSolutions names Zsolt Harsanyi as chairman
Emergent BioSolutions (NYSE:EBS) appointed Zsolt Harsanyi, independent director, as chairman of the board. EBS decided to eliminate the role of executive chairman in favor of an independent, non-executive chairman and will no longer require the role of lead independent director. Ronald Richard, current lead independent director, will continue as an independent director. Fuad El-Hibri, founder and executive chairman, will retire from EBS. He will serve as a consultant to EBS through Mar. 2024.
For further details see:
Emergent BioSolutions names Zsolt Harsanyi as chairman